1. Home
  2. DUO vs SSKN Comparison

DUO vs SSKN Comparison

Compare DUO & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$1.20

Market Cap

7.5M

Sector

Finance

ML Signal

HOLD

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.07

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUO
SSKN
Founded
2011
1989
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
8.9M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
DUO
SSKN
Price
$1.20
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
301.0K
70.9K
Earning Date
03-13-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$56,189,313.00
$30,980,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
48.30
N/A
52 Week Low
$1.14
$1.00
52 Week High
$11.46
$3.86

Technical Indicators

Market Signals
Indicator
DUO
SSKN
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
DUO
SSKN

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: